MindWalk Holdings Corp. Logo

MindWalk Holdings Corp.

A Bio-Native AI company that integrates AI and lab research for drug discovery.

HYFT | US

Overview

Corporate Details

ISIN(s):
CA45257F2008
LEI:
Country:
United States of America
Address:
INDUSTRIOUS, 823 CONGRESS AVE, SUITE 300, 78701 AUSTIN

Description

MindWalk Holdings Corp. is a Bio-Native AI company that focuses on transforming drug discovery and development. The company operates a biointelligence ecosystem that integrates artificial intelligence, multi-omics data, and advanced laboratory research to make complex biology computable and actionable. This unified platform is designed to accelerate the discovery and development of biologics, including therapeutic antibodies, diagnostics, vaccines, and peptide therapeutics, from target identification through to the clinical stage. Its capabilities are powered by proprietary technologies such as the patented HYFT® technology and the LensAI™ platform, which are adaptable to specific targets, modalities, and program priorities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all MindWalk Holdings Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MindWalk Holdings Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MindWalk Holdings Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Adaptive Biotechnologies Corp Logo
Decodes the adaptive immune system to develop products for diagnosing and treating disease.
United States of America
ADPT
Adeia Inc. Logo
R&D company that licenses IP for the media, entertainment, and semiconductor industries.
United States of America
ADEA
Aditxt, Inc. Logo
Acquires, develops, and deploys health technologies to address major health challenges.
United States of America
ADTX
Advanced Biomed Inc. Logo
Develops microfluidic biochip diagnostic systems for precision oncology.
United States of America
ADVB
AIM ImmunoTech Inc. Logo
Immuno-pharma company developing therapeutics for oncology, immune, and viral diseases.
United States of America
AIM
Ainos, Inc. Logo
Develops AI-driven diagnostics, immune therapeutics, and telehealth POCT devices.
United States of America
AIMD
Akero Therapeutics, Inc. Logo
Clinical-stage company developing treatments for serious metabolic diseases like MASH.
United States of America
AKRO
Aladdin Healthcare Technologies SE Logo
Develops AI-powered tools for drug discovery and diagnostics for age-related conditions.
Germany
NMI
Alaunos Therapeutics, Inc. Logo
Clinical-stage immuno-oncology company developing TCR-T cell therapies for solid tumors.
United States of America
TCRT
Aligos Therapeutics, Inc. Logo
A clinical-stage biopharmaceutical company developing therapeutics for liver and viral diseases.
United States of America
ALGS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.